TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

November 25, 2015

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, has granted Getinge Infection Control AB, a global leader in infection control solutions, exclusive global distributor rights to its FDA-cleared, STERIZONE VP4 Sterilizer for US$7.5 million, plus performance minimums

Previous Article
Advances in image sensor modules for endoscopic imaging: an interview with Martin Wäny
Advances in image sensor modules for endoscopic imaging: an interview with Martin Wäny

The miniaturisation, and in particular the usage of semiconductor miniaturisation technologies, allows us t...

Next Article
New drug may show promise against resistant melanomas
New drug may show promise against resistant melanomas

A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise ...